News

Progyny and RESOLVE to Launch National Infertility Awareness Week® by Ringing the Nasdaq Stock Market Opening Bell and Lighting the Empire State Building

The fertility benefits leader and national infertility nonprofit association take over the capital of the world to support the millions…

2 years ago

Forza Innovations Inc. Announces Sustainable Origins Update

SAN DIEGO, CA, April 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forza Innovations Inc.  (OTC Pink: FORZ) (the “Company”),…

2 years ago

Creative Health Care Management Celebrates National Nurses Week 2022 With a Complimentary Webinar for Nursing and Healthcare Professionals

Bloomington, April 19, 2022 (GLOBE NEWSWIRE) -- Today Creative Health Care Management announced it will celebrate National Nurses Week 2022…

2 years ago

InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand Hearing Aids & Related Products on BestBuy.com

InnerScope's Subsidiary HearingAssist II Inc. Signs Vendor Agreement with Best Buy to Offer Hearing Aids & Related Products sold in…

2 years ago

Dentsply Sirona Provides Corporate Update

John Groetelaars Named Interim Chief Executive Officer Barbara Bodem Named Interim Chief Financial Officer Company Provides Update on Anticipated First…

2 years ago

Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

2 years ago

eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer

Dr. Curtis succeeds Paul Sekhri, who remains on Board of Directors Reflects company’s focus on advancement of portfolio toward clinical…

2 years ago

USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.

The name change comes from the strong brand recognition garnered by the company’s flagship product, QHSLab WEST PALM BEACH, FL,…

2 years ago

Sharps Compliance Announces Third Quarter Fiscal 2022 Conference Call and Webcast

HOUSTON, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its third…

2 years ago

SCYNEXIS Secures Additional Commercial Insurance Formulary Coverage for BREXAFEMME® (ibrexafungerp tablets), Providing Access to an Estimated 93 Million Commercially-Insured Lives

Advanced first-in-class, one-day oral antifungal treatment, BREXAFEMME is now covered for approximately 55 percent of commercially-insured U.S. patientsJERSEY CITY, N.J.,…

2 years ago